Story
Lemonade Stock Declines Following Morgan Stanley Downgrade
Shares of Lemonade Inc. (NYSE:LMND) fell by 9% on Wednesday after Morgan Stanley downgraded the insurance technology company from "Overweight" to "Equalweight." Analyst Bob Huang set a price target of $75.00 for the stock.
The downgrade was primarily driven by valuation concerns, following a significant rally that saw Lemonade's shares increase by approximately 50% over the past month. In a note to clients, Huang stated, "we will step to the sidelines as we wait for the next major catalyst to emerge," adding that the current valuation now largely reflects the positive growth catalysts.
Despite the rating change, the analyst expressed continued belief in the company's fundamentals. The note highlighted Lemonade's "strong momentum, especially the tech-enabled growth and underwriting." The firm's investment thesis centers on Lemonade's path toward profitability and sustained long-term growth.
AdMorgan Stanley projects that Lemonade is positioned to achieve net income profitability by the end of 2027. The firm forecasts gross written premium growth of approximately 35% in 2026 and 30% in 2027. The analyst also noted that the company's ability to navigate a softening auto insurance market will be critical to its overall growth.